Literature DB >> 11709756

Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma.

Timothy D Howard1, Gerard H Koppelman, Jianfeng Xu, Siqun L Zheng, Dirkje S Postma, Deborah A Meyers, Eugene R Bleecker.   

Abstract

Asthma is a common respiratory disease that is characterized by variable airways obstruction caused by acute and chronic bronchial inflammation; associated phenotypes include bronchial hyperresponsiveness (BHR), elevated total serum immunoglobulin E (IgE) levels, and skin tests positive to common allergens. Binding of interleukin-13 (IL13) or interleukin-4 (IL4) to the IL4 receptor (IL4R) induces the initial response for Th2 lymphocyte polarization. Both IL13 and IL4 are produced by Th2 cells and are capable of inducing isotype class-switching of B-cells to produce IgE after allergen exposure. These cytokines also share a common receptor component, IL4R alpha. We have investigated five IL4RA single-nucleotide polymorphisms in a population of Dutch families ascertained through a proband with asthma. By considering the probands and their spouses as an unrelated sample, we observed significant associations of atopy and asthma-related phenotypes with several IL4RA polymorphisms, including S478P and total serum IgE levels (P=.0007). A significant gene-gene interaction between S478P in IL4RA and the -1111 promoter variation in IL13, previously shown to be associated with BHR (P=.003), was detected. Individuals with the risk genotype for both genes were at almost five times greater risk for the development of asthma compared to individuals with both non-risk genotypes (P=.0004). These data suggest that variations in IL4RA contribute to elevated total serum IgE levels, and interaction between IL4RA and IL13 markedly increases an individual's susceptibility to asthma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709756      PMCID: PMC384891          DOI: 10.1086/338242

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Characterization of the membrane-bound and a soluble form of human IL-4 receptor alpha produced by alternative splicing.

Authors:  S Kruse; J Forster; J Kuehr; K A Deichmann
Journal:  Int Immunol       Date:  1999-12       Impact factor: 4.823

2.  Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations.

Authors:  C Ober; S A Leavitt; A Tsalenko; T D Howard; D M Hoki; R Daniel; D L Newman; X Wu; R Parry; L A Lester; J Solway; M Blumenthal; R A King; J Xu; D A Meyers; E R Bleecker; N J Cox
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

3.  Fluorescent allele-specific PCR (FAS-PCR) improves the reliability of single nucleotide polymorphism screening.

Authors:  T D Howard; E R Bleecker; O C Stine
Journal:  Biotechniques       Date:  1999-03       Impact factor: 1.993

4.  Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma.

Authors:  H Mitsuyasu; K Izuhara; X Q Mao; P S Gao; Y Arinobu; T Enomoto; M Kawai; S Sasaki; Y Dake; N Hamasaki; T Shirakawa; J M Hopkin
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

5.  Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma.

Authors:  W R Henderson; E Y Chi; C R Maliszewski
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

6.  Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

Authors:  L C Borish; H S Nelson; M J Lanz; L Claussen; J B Whitmore; J M Agosti; L Garrison
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

7.  Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.

Authors:  J M Drazen; C N Yandava; L Dubé; N Szczerback; R Hippensteel; A Pillari; E Israel; N Schork; E S Silverman; D A Katz; J Drajesk
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

8.  The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction.

Authors:  S Kruse; T Japha; M Tedner; S H Sparholt; J Forster; J Kuehr; K A Deichmann
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

9.  Linkage and allelic association of atopy and markers flanking the IL4-receptor gene.

Authors:  K A Deichmann; A Heinzmann; J Forster; S Dischinger; C Mehl; E Brueggenolte; F Hildebrandt; M Moseler; J Kuehr
Journal:  Clin Exp Allergy       Date:  1998-02       Impact factor: 5.018

10.  Requirement for IL-13 independently of IL-4 in experimental asthma.

Authors:  G Grünig; M Warnock; A E Wakil; R Venkayya; F Brombacher; D M Rennick; D Sheppard; M Mohrs; D D Donaldson; R M Locksley; D B Corry
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

View more
  99 in total

1.  IL-4 receptor α polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist.

Authors:  Rebecca E Slager; Gregory A Hawkins; Elizabeth J Ampleford; Alexandra Bowden; Lauren E Stevens; Matthew T Morton; Adrian Tomkinson; Sally E Wenzel; Malinda Longphre; Eugene R Bleecker; Deborah A Meyers
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

2.  IL-13 and adenosine: partners in a molecular dance?

Authors:  Gabriele Grünig
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

3.  Gene-based interaction analysis by incorporating external linkage disequilibrium information.

Authors:  Jing He; Kai Wang; Andrew C Edmondson; Daniel J Rader; Chun Li; Mingyao Li
Journal:  Eur J Hum Genet       Date:  2010-10-06       Impact factor: 4.246

Review 4.  Role of interleukin-13 in asthma.

Authors:  Jonathan Corren
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 5.  Gene-environment interactions in asthma: with apologies to William of Ockham.

Authors:  Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-01

6.  Ethnicity-specific gene-gene interaction between IL-13 and IL-4Ralpha among African Americans with asthma.

Authors:  Natalie C Battle; Shweta Choudhry; Hui-Ju Tsai; Celeste Eng; Gunjan Kumar; Kenneth B Beckman; Mariam Naqvi; Kelley Meade; H George Watson; Michael Lenoir; Esteban González Burchard
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

7.  Variation in doses and duration of particulate matter exposure in bronchial epithelial cells results in upregulation of different genes associated with airway disorders.

Authors:  Priya Tripathi; Furong Deng; Anne M Scruggs; Yahong Chen; Steven K Huang
Journal:  Toxicol In Vitro       Date:  2018-05-09       Impact factor: 3.500

8.  Polymorphisms of IL-4, IL-4R alpha, and AICDA genes in adult allergic asthma.

Authors:  Tianpen Cui; Lin Wang; Jianmin Wu; Lihua Hu; Jungang Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

Review 9.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

10.  Surfactant Protein-A Protects against IL-13-Induced Inflammation in Asthma.

Authors:  Dave Francisco; Ying Wang; Michelle Conway; Audriana N Hurbon; Alane B C Dy; Kenneth J Addison; Hong W Chu; Dennis R Voelker; Julie G Ledford; Monica Kraft
Journal:  J Immunol       Date:  2020-04-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.